
Atrophic acne scars (AAS) are among the most common long-term sequelae of acne vulgaris, resulting from collagen degradation and subsequent fibrosis after inflammatory resolution [1]. These scars are typically classified into three morphological types—icepick, boxcar, and rolling—each requiring...

Isotretinoin, a frequently prescribed treatment for severe acne vulgaris, is associated with rare but clinically important musculoskeletal adverse effects, notably sacroiliitis. Although previous studies reported an association, comprehensive long-term data on clinical outcomes, imaging progression,...

Atopic dermatitis (AD) is a complex, immune-mediated, chronic inflammatory skin disease characterized by intense pruritus and recurrent dry, red, and excoriated lesions which can have a significant impact on quality of life (QoL) and emotional well-being [1,2,3,4,5]. The prevalence of AD varies in different...

In 2023 and 2024, the American Academy of Dermatology published guidelines on the use of topical and systemic therapies for the management of atopic dermatitis (AD) in adults. Since the publication of these guidelines, several novel therapies have emerged to treat AD. To update previous guidelines on...

Acne vulgaris is a common skin condition characterized by excessive sebum production, inflammation, and compromised skin barrier function. Effective treatments should target both lesion reduction and skin hydration while maintaining tolerability.Objective: This study aimed to evaluate the efficacy and...